FindTrial
Sign In

Nasogastric and intravenous erythromycin as prokinetic in intensive care patients: a randomised controlled study

Nasogastric and intravenous erythromycin as prokinetic in intensive care patients: a randomised controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN94465562
Enrollment
Unknown
Registered
2003-09-12
Start date
2002-01-01
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Gastric emptying Signs and Symptoms Gastric emptying

Interventions

A 5 ml sample of blood will be taken for measuring baseline paracetamol content. 1.5 g of soluble paracetamol will be administered to them through their nasogastric tube. They will th

Sponsors

Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Intensive Care patients who will be recruited into the study if they exhibit a failure to absorb nasogastric feed.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026